Trusteesof the Griffin Institute
Professor Robin Kennedy, MS, FRCS
Chairman, Visiting professor of surgery, Imperial College London, Retired Consultant Colorectal Surgeon, St Mark’s Hospital, London
Robin Kennedy has worked as a consultant surgeon based in Somerset and, more recently, at St Mark’s Hospital, London, which specialises in bowel treatment. His work involved developing and testing new approaches in bowel surgery, particularly using keyhole (laparoscopic) techniques and enhanced recovery programmes. In 2013, he was appointed Adjunct Professor of Surgery in the Department of Surgery and Cancer, Imperial College London. Since 2016 he has been Chairman of Northwick Park Institute of Medical Research. He also teaches consultant surgeons in Denmark and is involved in the design of novel surgical equipment.
Mr Bruce Mauleverer, QC, FClArb, MA
Vice Chairman, Retired barrister
Bruce Mauleverer QC is a retired Barrister, Deputy High Court Judge, Arbitrator and Mediator. He is currently Patron of the International Law Association and Chairman of The Listen Charity. Since his retirement from professional practice, he has been a trustee of charities including UNICEF UK, MapAction, the Mortimer Society and The Tavistock Centre for Couple Relationships. He was also Chairman of The Jubilee Sailing Trust.
Bruce has many other interests including property law and governance issues in the voluntary sector.
Professor Vivek Mudera, PhD
Vice Dean Education Faculty of Medical Sciences and Director Division of Surgery and Interventional Science, University College London
Vivek Mudera is the Institute Director of Education at UCL Division of Surgery and Interventional Science. His main research themes include in vitro and in vivo musculoskeletal engineering and wound healing. He is the Director of Education at the Institute of Orthopaedics and Musculoskeletal Science, Graduate Tutor for the Division of Surgery and Interventional Sciences and Educational Lead on the Divisional Executive Committee.
Vivek is also an active member of the UK Tissue Engineering Community, and an elected member of the Engineering and Physical Sciences Research Council College. Highlights of his work include the investigation of the role of specific cell migration during flexor tendon healing and formation of adhesions; the prevention of adhesion formation using protein blockers to inhibit cell migration; and the identification of cellular mechanisms in Dupuytren’s Contracture and Frozen Shoulder.
Mr Hugo Robinson, MA, FCA
Treasurer, Partner at Kings Park Capital and a Fellow of The Institute of Chartered Accountants in England and Wales
(Bio coming soon)
Mr Simon Hubbert
Co-founder and Chief Executive Officer of RHYTHM AI Ltd, a UK-based medical technology company in the cardiac rhythm mapping space
Simon has over 25 years experience in the medical device industry and has held CEO, Senior commercial and general management position in both public and private global medtech companies, including Johnson & Johnson, Medtronic, Lombard Medical and LMA International.
Dr Janet Allen, MD, FRSE
Director of Strategic Innovation at The Cystic Fibrosis Trust
Janet Allen trained as a physician and practised in academic medical centres. Following post-doctoral training at Harvard Medical School, she gained faculty positions at the University of Cambridge and was then appointed Chair of Molecular Medicine at University of Glasgow. She moved to senior management posts in Parke Davis and then Pfizer.
Since 2002, Janet has been involved in developing research strategies for the Conway Institute at University College Dublin and for the Biotechnology and Biological Sciences Research Council. She joined the Cystic Fibrosis Trust in 2012, where she is now Director of Strategic Innovation.
Professor Anthony Goldstone, CBE
Professor of Haematology, Medical Director HCA UK at University College Hospital & Chair of the HCA UK Cancer Department
Professor Anthony Goldstone is the Medical Director at HCA UK at University College Hospital and Chair of the HCA UK Cancer Department.
Professor Goldstone joined University College Hospital in 1976 as a Consultant Haematologist and played a pivotal role in setting up the leukaemia and lymphoma transplant service there. He became the hospitals first Clinical Director in 1988 and the first Medical Director in 1992. He is the former Medical Director of the North London Cancer Network, former President of the British Society for Haematology and was awarded CBE in June 2008 for Services to Medicine. He also served as President of SOHO (Society of Haematological Oncology) a major International Haematology Clinical & research society.
Since HCA’s first NHS partnership in 2006 Professor Goldstone has been instrumental in the success of our longstanding partnership with University College Hospital and continues to support the joint venture in his role as Medical Director. Professor Goldstone is Chair of the HCA UK Cancer Department and facilitates our focus on innovation, quality improvement and growth within the department.
Professor Goldstone served as Chair of RNOH NHST for 8.5 years from Feb 2011. During that period the CQC rating improved from “Requires Improvement” to “Good”. Also during that period, the new Stanmore building at RNOH (Royal National Orthopaedic Hospital) was built & opened, the first significant new build on that site for 50 years. This added over 100 beds to the facility the vast majority of them single rooms.
Mr. Bertie Leigh Hon FRCA and FRCPCH, FRCOG ad eundem
Ex Senior partner at Hempsons Solicitors with extensive experience in clinical negligence, commonly acting for doctors and NHS Resolution. He has also advised a number of medical bodies and Royal Colleges. He is the former Chairman of NCEPOD and was Non-Executive Director on the Board of the Royal National Orthopaedic Hospital Stanmore. Member of Council British Orthopaedic Association and the Gross Negligence Manslaughter Committee advising the GMC.
(Bio coming soon)
(Bio coming soon)